Apogee Therapeutics (APGE) Capital Expenditures (2024 - 2026)
Apogee Therapeutics' (APGE) quarterly Capital Expenditures came in at -$155000.0 in Q1 2026, down 102.27% year-on-year from $6.8 million in Q1 2025, and up 95.43% on a QoQ basis from -$3.4 million in Q4 2025.
Apogee Therapeutics (APGE) Capital Expenditures (2024 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has 3 years of Capital Expenditures data on file, last reported at -$155000.0 in Q1 2026.
- On a quarterly basis, Capital Expenditures fell 102.27% year-over-year to -$155000.0 in Q1 2026; TTM through Mar 2026 was -$1.8 million, a 124.2% decrease from a year earlier, with the FY2025 full-year figure at $5.1 million, up 346.79% from the prior year.
- Capital Expenditures for Q1 2026 stood at -$155000.0, up from -$3.4 million in the prior quarter.
- Over the last five years, Capital Expenditures for APGE reached as high as $6.8 million in Q1 2025 and fell as low as -$3.4 million in Q4 2025.
- Historically, Capital Expenditures has averaged $682666.7 across 3 years, with a median of $51000.0 in 2024.
- On a YoY basis, Capital Expenditures climbed as much as 1849.0% in 2025 and fell as far as 339200.0% in 2025.
- Year by year, Capital Expenditures stood at -$1000.0 in 2024, then slumped by 339200.0% to -$3.4 million in 2025, then soared by 95.43% to -$155000.0 in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were -$155000.0 in Q1 2026, -$3.4 million in Q4 2025, and $3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Apogee Therapeutics | 9.35 Bn | 8.29 Bn | - | -155,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -155,000.00 |
| Mar 31, 2026 | -155,000.00 |
| Dec 31, 2025 | -3.39 Mn |
| Dec 31, 2025 | -3.39 Mn |
| Sep 30, 2025 | 3.46 Mn |
| Sep 30, 2025 | 3.46 Mn |
| Jun 30, 2025 | -1.76 Mn |
| Jun 30, 2025 | -1.76 Mn |
| Mar 31, 2025 | 6.84 Mn |
| Mar 31, 2025 | 6.84 Mn |
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2024 | 751,000.00 |
| Sep 30, 2024 | 751,000.00 |
| Jun 30, 2024 | 51,000.00 |
| Jun 30, 2024 | 51,000.00 |
| Mar 31, 2024 | 351,000.00 |
| Mar 31, 2024 | 351,000.00 |